HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tong Wu Selected Research

ONO-DI-004

4/2006Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
6/2005Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tong Wu Research Topics

Disease

187Neoplasms (Cancer)
04/2024 - 08/2002
58Inflammation (Inflammations)
05/2024 - 01/2004
44Infections
05/2024 - 09/2002
34Hepatocellular Carcinoma (Hepatoma)
01/2024 - 04/2002
25Cholangiocarcinoma
04/2024 - 08/2002
25Breast Neoplasms (Breast Cancer)
12/2023 - 09/2013
22Fibrosis (Cirrhosis)
02/2024 - 02/2015
21Neoplasm Metastasis (Metastasis)
03/2024 - 10/2013
20Carcinogenesis
03/2024 - 10/2004
20Leukemia
01/2024 - 06/2003
17Squamous Cell Carcinoma of Head and Neck
08/2023 - 01/2014
16Obesity
03/2023 - 04/2002
13COVID-19
12/2024 - 01/2020
13Wounds and Injuries (Trauma)
04/2024 - 02/2008
13Lung Neoplasms (Lung Cancer)
04/2024 - 07/2011
12Insulin Resistance
07/2023 - 08/2003
11Pain (Aches)
07/2023 - 01/2014
10Liver Diseases (Liver Disease)
11/2023 - 12/2008
10Liver Cirrhosis (Hepatic Cirrhosis)
10/2023 - 01/2014
10Body Weight (Weight, Body)
03/2023 - 09/2009
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 02/2004
9Liver Neoplasms (Liver Cancer)
01/2024 - 09/2003
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2015
8Atherosclerosis
02/2024 - 04/2002
8Alzheimer Disease (Alzheimer's Disease)
01/2024 - 12/2019
8Sarcoma (Soft Tissue Sarcoma)
12/2023 - 01/2020
7Neuroblastoma
01/2024 - 03/2010
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2010
6Retinoblastoma (Glioblastoma, Retinal)
01/2024 - 01/2017
6Stroke (Strokes)
12/2023 - 12/2018
6Fatigue
12/2023 - 06/2021
6Type 2 Diabetes Mellitus (MODY)
10/2023 - 12/2019
6Hypoxia (Hypoxemia)
07/2023 - 01/2020
6Carcinoma (Carcinomatosis)
01/2023 - 10/2014
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 05/2016
5Meningitis
04/2024 - 01/2010
5Glioblastoma (Glioblastoma Multiforme)
04/2024 - 01/2018
5Virus Diseases (Viral Diseases)
04/2024 - 11/2013
5Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2015
5Osteoarthritis
07/2023 - 01/2013
5Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 08/2004
5Autoimmune Diseases (Autoimmune Disease)
12/2022 - 10/2015
5Glioma (Gliomas)
01/2022 - 04/2016

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2013
40Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2017
22LipidsIBA
03/2024 - 04/2002
21RNA (Ribonucleic Acid)IBA
01/2024 - 01/2011
21CytokinesIBA
12/2023 - 01/2004
19MicroRNAs (MicroRNA)IBA
04/2024 - 07/2012
17Messenger RNA (mRNA)IBA
08/2023 - 06/2003
15Glucose (Dextrose)FDA LinkGeneric
04/2024 - 08/2003
14EnzymesIBA
04/2024 - 04/2002
14Long Noncoding RNAIBA
01/2024 - 10/2018
14Dinoprostone (PGE2)FDA Link
01/2023 - 10/2004
13Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2014 - 08/2002
10Immune Checkpoint InhibitorsIBA
04/2024 - 01/2019
10LigandsIBA
02/2024 - 07/2003
9DNA (Deoxyribonucleic Acid)IBA
01/2024 - 09/2002
9Docosahexaenoic AcidsIBA
01/2018 - 01/2008
9ProstaglandinsIBA
09/2009 - 08/2002
8Therapeutic UsesIBA
01/2024 - 01/2020
8Phosphotransferases (Kinase)IBA
12/2023 - 04/2006
8Antiviral Agents (Antivirals)IBA
01/2023 - 08/2006
8Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 01/2011
7Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 05/2014
7Interleukin-6 (Interleukin 6)IBA
02/2024 - 08/2002
7Peptides (Polypeptides)IBA
12/2023 - 01/2019
7CarbonIBA
03/2023 - 08/2016
7CholesterolIBA
02/2023 - 02/2010
7Prostaglandins EIBA
01/2023 - 08/2002
7Metal-Organic FrameworksIBA
10/2022 - 01/2020
7AntigensIBA
10/2022 - 12/2010
7Small Interfering RNA (siRNA)IBA
10/2022 - 06/2005
715-hydroxyprostaglandin dehydrogenaseIBA
03/2022 - 01/2008
7Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2015 - 01/2008
6Transcription Factors (Transcription Factor)IBA
04/2024 - 12/2006
6ChemokinesIBA
02/2024 - 03/2016
6Chimeric Antigen ReceptorsIBA
01/2024 - 11/2020
6AntioxidantsIBA
03/2023 - 01/2020
6ElementsIBA
03/2022 - 12/2010
5Indicators and Reagents (Reagents)IBA
04/2024 - 08/2006
5CateninsIBA
02/2024 - 01/2011
5Sorafenib (BAY 43-9006)FDA Link
01/2024 - 12/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2023 - 01/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2013
5ZincIBA
09/2022 - 07/2011
5Phenobarbital (Luminal)FDA Link
02/2022 - 09/2013
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 12/2008
5Fibronectins (Fibronectin)IBA
01/2022 - 01/2020
5Alanine Transaminase (SGPT)IBA
01/2022 - 12/2008

Therapy/Procedure

78Therapeutics
04/2024 - 08/2006
26Drug Therapy (Chemotherapy)
05/2024 - 07/2005
21Immunotherapy
04/2024 - 06/2012
20Hematopoietic Stem Cell Transplantation
01/2024 - 02/2004
18Transplantation
01/2023 - 09/2003
8Radiotherapy
01/2023 - 07/2005
8Chemoprevention
01/2022 - 07/2005
7Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2024 - 03/2019
6Stem Cell Transplantation
01/2024 - 06/2008
6Photochemotherapy (Photodynamic Therapy)
10/2022 - 10/2017